Posts Tagged: Cedars-Sinai
Stem cell research in what's known as the "PCR strip." (Image: Science Photo, via Shutterstock)
The California stem cell agency yesterday handed out $75 million, doubling down on a couple of efforts to develop a stem cell therapy and a stem cell tool, plus funding an expansion of its Alpha Clinic network with two new, Northern California sites. The awards bring to $2.34 billion that the nearly 13-year-old agency has committed to stem cell research.
A Liquid Nitrogen bank containing a suspension of stem cells. (Photo: Elena Pavlovich)
The California stem cell agency this week approved nearly $33 million for clinical stage research projects testing treatments for type 1 diabetes, arthritis of the knee, ALS and an immunodeficiency affliction.
Examining a liquid nitrogen bank containing suspended stem cells. (Photo: Elena Pavolvich)
You might say it is a case of “self-control” involving the test of a stem cell therapy for an infamous and terrible disease. Not self-control in the usual sense, but in the sense of controls during a clinical trial for a treatment prior to its release to the general public.